Explore News
-
Why the UK-US Trade Deal Threatens NHS Funding
Trade agreement may lead to significant reduction in other NHS services
-
Why Insulin Remains a Luxury for Many Diabetics
Diabetes patients struggle to access lifesaving insulin due to high costs and supply chain issues
-
Only 12% of Drugs Saw Price Drops Under Trump Initiative
Despite high-profile negotiations and executive actions, most prescription drug prices have risen since President Trump
-
Why Xanax XR Recall Matters: A Nationwide Health Alert
Nationwide recall issued due to dissolution specification failures
-
Purdue Pharma Dissolution Reveals New Era in Opioid Crisis
OxyContin maker to be replaced by new company aiming to combat opioid crisis
-
AI-Designed Drugs: A New Era in Medicine
A significant breakthrough in artificial intelligence
-
Novartis CEO Warns of Looming Drug Pricing Reality
Drug pricing policy under Trump poses difficulties
-
Why Xanax XR Batch Was Recalled by FDA
Nationwide recall of Xanax XR due to failed dissolution specs
